Archives: Speakers

Anne Liebgott is founder of the online platform AW✚SWITZERLAND at americanswelcome.swiss, introducing wealth managers registered with the Securities and Exchange Commission in the United States dedicated to providing compliant wealth management services to US, Canadian, and Latin American citizens, residents, and expats. The platform also includes other wealth management-related services. In addition, Anne is the founder of AW❖UNITED KINGDOM and AW●ASIA PACIFIC | MIDDLE EAST. She also provides US-oriented, digital, and traditional marketing, communication, and business development strategies through her agency, Americom.

Experienced expert with a demonstrated history of working in IP Licensing, bussiness development and corporate operation in biotechology industry. Skilled in IP management, IP due diligence, Technology assessment，Patent licensing, Deal making, start-up making and Life Sciences. Strong IP legal & business professional with a Doctor of Philosophy (Ph.D.) focused in Pharmacology from Chinese Academy of Sciences.

Especializada en el mundo de la Publicidad y Marketing, donde después de casi 8 años trabajando en Telefonica, los últimos 5 los he dedicado al desarrollo de negocio y gestión de proyectos de Big Data enfocados a dar salida a nuestra solución de Smart Steps en sectores como la publicidad, el retail, el marketing y la movilidad. Trabajamos transformando la recopilación masiva de los datos de tráfico de nuestra red -debidamente agregados y anonimizados- en análisis avanzados de movilidad y patrones de comportamiento que puedan ayudar tanto a empresas del sector publico como privado.

Cuento con casi tres años de experiencia en el área de negocio de Telefónica y en los últimos meses, me he especializado en proyectos de Big Data, incluyendo Smart Steps. Trabajo directamente con clientes de primer nivel en sectores como turismo, movilidad, retail, publicidad y administración pública, ayudándoles a aprovechar al máximo la herramienta. Combino visión estratégica y análisis de datos con una relación cercana con el cliente, impulsando la toma de decisiones y generando valor en distintos ámbitos.

Soy Juan Tapia Torán y llevo más de seis años trabajando en Telefónica como Project Manager, especializado en la gestión de proyectos de Big Data en la plataforma Smart Steps. Lidero proyectos de soluciones de Big Data dirigidas a los sectores de turismo, movilidad, retail y publicidad, apoyando a empresas y administraciones públicas en la toma de decisiones basadas en los Insights de nuestra plataforma. 

Dr. Philipp Schatz is a seasoned expert in precision medicine and in vitro diagnostics (IVD) with over 20 years of experience. Currently, he serves as the Global Regulatory Lead for IVD at Bayer, where he has spearheaded the development of regulatory strategies for oncology projects, achieving significant milestones such as the approval of Bayer’s first companion diagnostic in the US and Japan.

Prior to his role at Bayer, Dr. Schatz was a Diagnostic Expert in AstraZeneca’s Precision Medicine Unit and held various positions in CROs and the IVD industry. He has published over 20 peer-reviewed articles and is actively engaged in scientific committees, including the Precision Medicine Working Group of the EFPIA. Dr. Schatz holds a Doctor of Natural Sciences (Dr. rer. nat.) in Epigenetics from the University of Saarland. He is also a member of the Scientific Advisory Board for the PoC-ID Consortium, a work package leader for the BestAgeing consortium, and a member of both the European Society for Medical Oncology (ESMO) and the German Society of Cardiologists (DGK).

Talia Milosevic is a Director, Clinical Safety at the Surgical division of Edwards Lifesciences, global company,  focused on developing solutions for patients suffering from structural heart disease.

With more than 18 years of experience in patient safety and clinical research, Talia has a proven track record in safety risk management, cross-functional safety governance, and implementing safety strategies in complex environment of global medical device studies under various regulatory requirements.

Talia is passionate about advancing innovative therapies while ensuring the highest standards of patient safety.